Month: December 2009

FDA denies approval to long acting testosterone injections

Endo’s drug is Nebido, a long acting injectable (testosterone undecanoate) , that has been available in Europe, Mexico, and many countries for years. It requires injections every three to four mouths instead of every week or two. Too bad the FDA made this decision. This shows how difficult it is getting drugs approved now at …

FDA denies approval to long acting testosterone injections Read More »